Peritoneal sarcomatosis in pediatric malignancies

Pediatric Blood and Cancer

Volumn 60, Issue 1, 2013, Pages 12-17

  Huh, Winston W ^a   Fitzgerald, Nancy E ^a   Mahajan, Anita ^a   Hayes Jordan, Andrea ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Childhood cancer; Intraperitoneal; Pediatric; Sarcoma; Sarcomatosis

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR7; FLUORODEOXYGLUCOSE F 18; IRINOTECAN; STROMAL CELL DERIVED FACTOR 1; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR TWIST; UVOMORULIN; VASCULOTROPIN A; VINCRISTINE;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER PALLIATIVE THERAPY; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CHILDHOOD CANCER; CLINICAL FEATURE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONSTIPATION; CYTOREDUCTIVE SURGERY; DESMOPLASTIC SMALL ROUND CELL TUMOR; DIFFUSION WEIGHTED IMAGING; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL STROMAL TUMOR; HUMAN; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; HYPERTHERMIC THERAPY; INTENSITY MODULATED RADIATION THERAPY; LEIOMYOSARCOMA; LIPOSARCOMA; LONG TERM CARE; NAUSEA; OUTCOME ASSESSMENT; PERITONEUM METASTASIS; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION DOSE; REVIEW; RHABDOMYOSARCOMA; TUMOR REGRESSION; TUMOR VOLUME; UPREGULATION; URINARY TRACT OBSTRUCTION;

CHILD; DESMOPLASTIC SMALL ROUND CELL TUMOR; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; HYPERTHERMIA, INDUCED; PERITONEAL NEOPLASMS; PHOTOCHEMOTHERAPY; RHABDOMYOSARCOMA; SARCOMA; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84870201495     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24293     Document Type: Review

References (77)

1. Crist WM, Anderson JR, Meza JL, et al. Intergroup rhabdomyosarcoma study-IV: Results for patients with nonmetastatic disease. J Clin Oncol 2001; 19: 3091-3102.
2. Ferrari A, Miceli R, Rey A, et al. Non-metastatic unresected paediatric non-rhabdomyosarcoma soft tissue sarcomas: Results of a pooled analysis from United States and European groups. Eur J Cancer 2011; 47: 724-731.
3. Karakousis CP, Blumenson LE, Canavese G, et al. Surgery for disseminated abdominal sarcoma. Am J Surg 1992; 163: 560-564.
4. Kunisaki C, Shimada H, Akiyama H, et al. Therapeutic outcomes of continuous hyperthermic peritoneal perfusion against advanced gastric cancer with peritoneal carcinomatosis. Hepatogastroenterology 2006; 53: 473-478.
5. Sugarbaker PH, Jablonski KA. Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg 1995; 221: 124-132.
6. de Bree E, Romanos J, Michalakis J, et al. Intraoperative hyperthermic intraperitoneal chemotherapy with docetaxel as second-line treatment for peritoneal carcinomatosis of gynaecological origin. Anticancer Res 2003; 23: 3019-3027.
7. Glehen O, Mithieux F, Osinsky D, et al. Surgery combined with peritonectomy procedures and intraperitoneal chemohyperthermia in abdominal cancers with peritoneal carcinomatosis: A phase II study. J Clin Oncol 2003; 21: 799-806.
8. Bilimoria MM, Holtz DJ, Mirza NQ, et al. Tumor volume as a prognostic factor for sarcomatosis. Cancer 2002; 94: 2441-2446.
9. Mudan SS, Conlon KC, Woodruff JM, et al. Salvage surgery for patients with recurrent gastrointestinal sarcoma: Prognostic factors to guide patient selection. Cancer 2000; 88: 66-74.
10. Hayes-Jordan A, Anderson P, Curley S, et al. Continuous hyperthermic peritoneal perfusion for desmoplastic small round cell tumor. J Pediatr Surg 2007; 42: E29-E32.
11. Kaste SC, Marina N, Fryrear R, et al. Peritoneal metastases in children with cancer. Cancer 1998; 83: 385-390.
12. Pawel BR, de Chadarevian JP, Inniss S, et al. Mesenteric pleomorphic liposarcoma in an adolescent. Arch Pathol Lab Med 1997; 121: 173-176.
13. Cypriano MS, Jenkins JJ, Pappo AS, et al. Pediatric gastrointestinal stromal tumors and leiomyosarcoma. Cancer 2004; 101: 39-50.
14. Prakash S, Sarran L, Socci N, et al. Gastrointestinal stromal tumors in children and young adults: A clinicopathologic, molecular, and genomic study of 15 cases and review of the literature. J Pediatr Hematol Oncol 2005; 27: 179-187.
15. Iwasaki M, Kitaguchi K, Kobayashi H. Mesenteric leiomyosarcoma in a 13-year-old boy. J Pediatr Surg 2010; 45: 1893-1895.
16. Hompes D, D'Hoore A, Van Cutsem E, et al. The treatment of peritoneal carcinomatosis of colorectal cancer with complete cytoreductive surgery and hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) with oxaliplatin: A Belgian multicentre prospective phase II clinical study. Ann Surg Oncol 2012; 19: 2186-2194.
17. Ceelen WP, Van Nieuwenhove Y, Van Belle S, et al. Cytoreduction and hyperthermic intraperitoneal chemoperfusion in women with heavily pretreated recurrent ovarian cancer. Ann Surg Oncol 2012; 19: 2352-2359.
18. Horowitz J, Spellman JE Jr, Driscoll DL, et al. An institutional review of sarcomas of the large and small intestine. J Am Coll Surg 1995; 180: 465-471.
19. Ogose A, Morita T, Hotta T, et al. Intra-abdominal metastases in musculoskeletal sarcomas. J Orthop Sci 2000; 5: 463-469.
20. Zanarini D, Sugarbaker PH. Extremity soft tissue sarcoma with metastases to abdominopelvic surfaces. J Surg Oncol 1997; 64: 68-72; discussion 72-63.
21. Chouli M, Viala J, Dromain C, et al. Intra-abdominal desmoplastic small round cell tumors: CT findings and clinicopathological correlations in 13 cases. Eur J Radiol 2005; 54: 438-442.
22. Bellah R, Suzuki-Bordalo L, Brecher E, et al. Desmoplastic small round cell tumor in the abdomen and pelvis: Report of CT findings in 11 affected children and young adults. AJR Am J Roentgenol 2005; 184: 1910-1914.
23. Pickhardt PJ, Fisher AJ, Balfe DM, et al. Desmoplastic small round cell tumor of the abdomen: Radiologic-histopathologic correlation. Radiology 1999; 210: 633-638.
24. Zhang WD, Li CX, Liu QY, et al. CT, MRI, and FDG-PET/CT imaging findings of abdominopelvic desmoplastic small round cell tumors: Correlation with histopathologic findings. Eur J Radiol 2011; 80: 269-273.
25. Kusamura S, Baratti D, Zaffaroni N, et al. Pathophysiology and biology of peritoneal carcinomatosis. World J Gastrointest Oncol 2010; 2: 12-18.
26. Bai F, Guo X, Yang L, et al. Establishment and characterization of a high metastatic potential in the peritoneum for human gastric cancer by orthotopic tumor cell implantation. Dig Dis Sci 2007; 52: 1571-1578.
27. Terauchi M, Kajiyama H, Yamashita M, et al. Possible involvement of TWIST in enhanced peritoneal metastasis of epithelial ovarian carcinoma. Clin Exp Metastasis 2007; 24: 329-339.
28. Yoshida J, Horiuchi A, Kikuchi N, et al. Changes in the expression of E-cadherin repressors, Snail, Slug, SIP1, and Twist, in the development and progression of ovarian carcinoma: The important role of snail in ovarian tumorigenesis and progression. Med Mol Morphol 2009; 42: 82-91.
29. Davis IJ, McFadden AW, Zhang Y, et al. Identification of the receptor tyrosine kinase c-Met and its ligand, hepatocyte growth factor, as therapeutic targets in clear cell sarcoma. Cancer Res 2010; 70: 639-645.
30. Diomedi-Camassei F, McDowell HP, De Ioris MA, et al. Clinical significance of CXC chemokine receptor-4 and c-Met in childhood rhabdomyosarcoma. Clin Cancer Res 2008; 14: 4119-4127.
31. Rees H, Williamson D, Papanastasiou A, et al. The MET receptor tyrosine kinase contributes to invasive tumour growth in rhabdomyosarcomas. Growth Factors 2006; 24: 197-208.
32. Watanabe T, Tsuda M, Makino Y, et al. Adaptor molecule Crk is required for sustained phosphorylation of Grb2-associated binder 1 and hepatocyte growth factor-induced cell motility of human synovial sarcoma cell lines. Mol Cancer Res 2006; 4: 499-510.
33. Carmignani CP, Sugarbaker TA, Bromley CM, et al. Intraperitoneal cancer dissemination: Mechanisms of the patterns of spread. Cancer Metastasis Rev 2003; 22: 465-472.
34. Ceelen WP, Bracke ME. Peritoneal minimal residual disease in colorectal cancer: Mechanisms, prevention, and treatment. Lancet Oncol 2009; 10: 72-79.
35. Yamamura S, Matsumura N, Mandai M, et al. The activated transforming growth factor-beta signaling pathway in peritoneal metastases is a potential therapeutic target in ovarian cancer. Int J Cancer 2012; 130: 20-28.
36. Grymula K, Tarnowski M, Wysoczynski M, et al. Overlapping and distinct role of CXCR7-SDF-1/ITAC and CXCR4-SDF-1 axes in regulating metastatic behavior of human rhabdomyosarcomas. Int J Cancer 2010; 127: 2554-2568.
37. Libura J, Drukala J, Majka M, et al. CXCR4-SDF-1 signaling is active in rhabdomyosarcoma cells and regulates locomotion, chemotaxis, and adhesion. Blood 2002; 100: 2597-2606.
38. Gerber SA, Rybalko VY, Bigelow CE, et al. Preferential attachment of peritoneal tumor metastases to omental immune aggregates and possible role of a unique vascular microenvironment in metastatic survival and growth. Am J Pathol 2006; 169: 1739-1752.
39. Gore RM, Meyers MA. Pathways of abdominal and pelvic disease spread. In: Gore RM, Levine MS, editors. Textbook of gastrointestinal radiology, 3rd edition. Philadelphia: Saunders; 2008. pp. 2099-2118.
40. Suwatanapongched T, Gierada DS. CT of thoracic lymph nodes. Part I: Anatomy and drainage. Br J Radiol 2006; 79: 922-928.
41. Oei TN, Jagannathan JP, Ramaiya N, et al. Peritoneal sarcomatosis versus peritoneal carcinomatosis: Imaging findings at MDCT. AJR Am J Roentgenol 2010; 195: W229-W235.
42. Leung RS, Calder A, Roebuck D. Embryonal rhabdomyosarcoma of the omentum: Two cases occurring in children. Pediatr Radiol 2009; 39: 865-868.
43. Low RN. MR imaging of the peritoneal spread of malignancy. Abdom Imaging 2007; 32: 267-283.
44. Hawkins DS, Conrad EU III, Butrynski JE, et al. [F-18]-fluorodeoxy-D-glucose-positron emission tomography response is associated with outcome for extremity osteosarcoma in children and young adults. Cancer 2009; 115: 3519-3525.
45. Hawkins DS, Schuetze SM, Butrynski JE, et al. [18F]Fluorodeoxyglucose positron emission tomography predicts outcome for Ewing sarcoma family of tumors. J Clin Oncol 2005; 23: 8828-8834.
46. Klem ML, Grewal RK, Wexler LH, et al. PET for staging in rhabdomyosarcoma: An evaluation of PET as an adjunct to current staging tools. J Pediatr Hematol Oncol 2007; 29: 9-14.
47. Volker T, Denecke T, Steffen I, et al. Positron emission tomography for staging of pediatric sarcoma patients: Results of a prospective multicenter trial. J Clin Oncol 2007; 25: 5435-5441.
48. Msika S, Gruden E, Sarnacki S, et al. Cytoreductive surgery associated to hyperthermic intraperitoneal chemoperfusion for desmoplastic round small cell tumor with peritoneal carcinomatosis in young patients. J Pediatr Surg 2010; 45: 1617-1621.
49. Hayes-Jordan A, Green H, Ludwig J, et al. Toxicity of hyperthermic intraperitoneal chemotherapy (HIPEC) in pediatric patients with sarcomatosis/carcinomatosis: Early experience and phase 1 results. Pediatr Blood Cancer 2012; 59: 395-397.
50. Sugarbaker PH, Welch LS, Mohamed F, et al. A review of peritoneal mesothelioma at the Washington Cancer Institute. Surg Oncol Clin N Am 2003; 12: 605-621, xi.
51. Glehen O, Kwiatkowski F, Sugarbaker PH, et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: A multi-institutional study. J Clin Oncol 2004; 22: 3284-3292.
52. Sugarbaker PH. A curative approach to peritoneal carcinomatosis from colorectal cancer. Semin Oncol 2005; 32: S68-S73.
53. Sugarbaker PH. Cytoreductive surgery and perioperative intraperitoneal chemotherapy: A new standard of care for appendiceal mucinous tumors with peritoneal dissemination. Clin Colon Rectal Surg 2005; 18: 204-214.
54. Glehen O, Gilly FN, Sugarbaker PH. New perspectives in the management of colorectal cancer: What about peritoneal carcinomatosis? Scand J Surg 2003; 92: 178-179.
55. Gough DB, Donohue JH, Schutt AJ, et al. Pseudomyxoma peritonei. Long-term patient survival with an aggressive regional approach. Ann Surg 1994; 219: 112-119.
56. Farma JM, Pingpank JF, Libutti SK, et al. Limited survival in patients with carcinomatosis from foregut malignancies after cytoreduction and continuous hyperthermic peritoneal perfusion. J Gastrointest Surg 2005; 9: 1346-1353.
57. Yan TD, Black D, Savady R, et al. Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma. J Clin Oncol 2006; 24: 4011-4019.
58. Yan TD, Edwards G, Alderman R, et al. Morbidity and mortality assessment of cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma-A prospective study of 70 consecutive cases. Ann Surg Oncol 2007; 14: 515-525.
59. Sugarbaker PH, Alderman R, Edwards G, et al. Prospective morbidity and mortality assessment of cytoreductive surgery plus perioperative intraperitoneal chemotherapy to treat peritoneal dissemination of appendiceal mucinous malignancy. Ann Surg Oncol 2006; 13: 635-644.
60. Feldman AL, Libutti SK, Pingpank JF, et al. Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy. J Clin Oncol 2003; 21: 4560-4567.
61. Park BJ, Alexander HR, Libutti SK, et al. Treatment of primary peritoneal mesothelioma by continuous hyperthermic peritoneal perfusion (CHPP). Ann Surg Oncol 1999; 6: 582-590.
62. Lim SJ, Cormier JN, Feig BW, et al. Toxicity and outcomes associated with surgical cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with sarcomatosis. Ann Surg Oncol 2007; 14: 2309-2318.
63. Lal DR, Su WT, Wolden SL, et al. Results of multimodal treatment for desmoplastic small round cell tumors. J Pediatr Surg 2005; 40: 251-255.
64. Hayes-Jordan A, Green H, Fitzgerald N, et al. Novel treatment for desmoplastic small round cell tumor: Hyperthermic intraperitoneal perfusion. J Pediatr Surg 2010; 45: 1000-1006.
65. Ballo MT, Zagars GK, Pollock RE, et al. Retroperitoneal soft tissue sarcoma: An analysis of radiation and surgical treatment. Int J Radiat Oncol Biol Phys 2007; 67: 158-163.
66. Pham TH, Iqbal CW, Zarroug AE, et al. Retroperitoneal sarcomas in children: Outcomes from an institution. J Pediatr Surg 2007; 42: 829-833.
67. Smith KB, Indelicato DJ, Knapik JA, et al. Definitive radiotherapy for unresectable pediatric and young adult nonrhabdomyosarcoma soft tissue sarcoma. Pediatr Blood Cancer 2011; 57: 247-251.
68. Tseng WH, Martinez SR, Do L, et al. Lack of survival benefit following adjuvant radiation in patients with retroperitoneal sarcoma: A SEER analysis. J Surg Res 2010; 168: e173-e180.
69. Amorino GP, Hercules SK, Mohr PJ, et al. Preclinical evaluation of the orally active camptothecin analog, RFS-2000 (9-nitro-20(S)-camptothecin) as a radiation enhancer. Int J Radiat Oncol Biol Phys 2000; 47: 503-509.
70. Omura M, Torigoe S, Kubota N. SN-38, a metabolite of the camptothecin derivative CPT-11, potentiates the cytotoxic effect of radiation in human colon adenocarcinoma cells grown as spheroids. Radiother Oncol 1997; 43: 197-201.
71. Dougherty TJ, Gomer CJ, Henderson BW, et al. Photodynamic therapy. J Natl Cancer Inst 1998; 90: 889-905.
72. Hahn SM, Fraker DL, Mick R, et al. A phase II trial of intraperitoneal photodynamic therapy for patients with peritoneal carcinomatosis and sarcomatosis. Clin Cancer Res 2006; 12: 2517-2525.
73. Gross SA, Wolfsen HC. The role of photodynamic therapy in the esophagus. Gastrointest Endosc Clin N Am 2010; 20: 35-53, vi.
74. Sanchez A, Reza M, Blasco JA, et al. Effectiveness, safety, and cost-effectiveness of photodynamic therapy in Barrett's esophagus: A systematic review. Dis Esophagus 2010; 23: 633-640.
75. Tanaka T, Matono S, Nagano T, et al. Photodynamic therapy for large superficial squamous cell carcinoma of the esophagus. Gastrointest Endosc 2011; 73: 1-6.
76. Wilson JJ, Jones H, Burock M, et al. Patterns of recurrence in patients treated with photodynamic therapy for intraperitoneal carcinomatosis and sarcomatosis. Int J Oncol 2004; 24: 711-717.
77. Canter RJ, Mick R, Kesmodel SB, et al. Intraperitoneal photodynamic therapy causes a capillary-leak syndrome. Ann Surg Oncol 2003; 10: 514-524.